PRINCETON, N.J., Nov. 05, 2020 /PRNewswire-PRWeb/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, delivering powerful insight into clinical trial development in bringing new therapies to people worldwide, today announced the new Client Services and Delivery organization, led by Brad Dean as Senior Vice President. The new organization will allow for all facets of client management and solution delivery to be unified by centralizing account management, project management, site services, clinical data management, and operations.
"Brad's deep experience and insight into our markets, along with his passion for exceeding our clients' expectations, gives him a unique perspective as we deliver on our industry-leading service and capabilities," said Euan Menzies, Chairman and CEO.
Included in the organization is Bioclinica's best-in-class project management team, focused on customer satisfaction and quality of services. Brad recently expanded this team by providing additional resources in Munich, Germany, to support studies outside the US.
"It is critical that we deliver our full suite of solutions, including our expanding capabilities to our clients in a high-quality manner," said Brad. "We continue to build our team and retain strong talent, which is the foundation for service delivery and successful study outcomes."
Brad has over 20 years of industry experience and has been with Bioclinica for the past 16 years. During his tenure, Brad has held positions of increasing responsibility in project management, pricing and proposals, mergers and acquisitions, and enterprise sponsors and portfolio management. Prior to joining Bioclinica, Brad held leadership positions in several clinical research organizations. In addition, he successfully served in the United States Peace Corps in Malawi, Africa as a Biology teacher.
About Bioclinica
Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market for people around the world. Through deep medical, scientific and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica's global team of life science experts serve more than 500 pharmaceutical, biotechnology, and device organizations – including the top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia. For more information, visit http://www.bioclinica.com.
SOURCE Bioclinica
Share this article